Zhang C, Zhang Y, Zhuang R, Yang K, Chen L, Jin B
Int J Mol Sci. 2024; 25(8).
PMID: 38674036
PMC: 11050295.
DOI: 10.3390/ijms25084451.
Kim J, Copperi F, Diano S
Physiology (Bethesda). 2023; 39(1).
PMID: 37962895
PMC: 11283896.
DOI: 10.1152/physiol.00021.2023.
Kaur T, Ohlemiller K, Warchol M
J Comp Neurol. 2017; 526(5):824-835.
PMID: 29218724
PMC: 5903687.
DOI: 10.1002/cne.24369.
Ishida Y, Kimura A, Nosaka M, Kuninaka Y, Hemmi H, Sasaki I
Sci Rep. 2017; 7(1):16833.
PMID: 29203799
PMC: 5714949.
DOI: 10.1038/s41598-017-17007-8.
Cardona S, Mendiola A, Yang Y, Adkins S, Torres V, Cardona A
ASN Neuro. 2015; 7(5).
PMID: 26514658
PMC: 4641555.
DOI: 10.1177/1759091415608204.
Role of fractalkine/CX3CL1 and its receptor in the pathogenesis of inflammatory and malignant diseases with emphasis on B cell malignancies.
Ferretti E, Pistoia V, Corcione A
Mediators Inflamm. 2014; 2014:480941.
PMID: 24799766
PMC: 3985314.
DOI: 10.1155/2014/480941.
Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches.
Santa-Marta M, de Brito P, Godinho-Santos A, Goncalves J
Front Immunol. 2013; 4:343.
PMID: 24167505
PMC: 3807056.
DOI: 10.3389/fimmu.2013.00343.
SDF-1alpha is a potent inducer of HIV-1-Specific CD8+ T-cell chemotaxis, but migration of CD8+ T cells is impaired at high viral loads.
Meditz A, Schlichtemeier R, Folkvord J, Givens M, Lesh K, Ray M
AIDS Res Hum Retroviruses. 2008; 24(7):977-85.
PMID: 18671480
PMC: 2927034.
DOI: 10.1089/aid.2007.0259.
Host factors influencing susceptibility to HIV infection and AIDS progression.
Lama J, Planelles V
Retrovirology. 2007; 4:52.
PMID: 17651505
PMC: 1978541.
DOI: 10.1186/1742-4690-4-52.
Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients.
Dimberg J, Dienus O, Lofgren S, Hugander A, Wagsater D
Int J Colorectal Dis. 2007; 22(10):1195-200.
PMID: 17611763
DOI: 10.1007/s00384-007-0343-6.
Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in North India.
Suresh P, Wanchu A, Sachdeva R, Bhatnagar A
J Clin Immunol. 2006; 26(5):476-84.
PMID: 16865553
DOI: 10.1007/s10875-006-9036-0.
Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression.
Bleiber G, May M, Martinez R, Meylan P, Ott J, Beckmann J
J Virol. 2005; 79(20):12674-80.
PMID: 16188970
PMC: 1235818.
DOI: 10.1128/JVI.79.20.12674-12680.2005.
Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration.
Chan C, Tuo J, Bojanowski C, Csaky K, Green W
Histol Histopathol. 2005; 20(3):857-63.
PMID: 15944936
PMC: 1930145.
DOI: 10.14670/HH-20.857.
Polymorphism of human and primate RANTES, CX3CR1, CCR2 and CXCR4 genes with regard to HIV/SIV infection.
Puissant B, Abbal M, Blancher A
Immunogenetics. 2003; 55(5):275-83.
PMID: 12879309
DOI: 10.1007/s00251-003-0588-3.
Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.
McDermott D, Fong A, Yang Q, Sechler J, Cupples L, Merrell M
J Clin Invest. 2003; 111(8):1241-50.
PMID: 12697743
PMC: 152935.
DOI: 10.1172/JCI16790.
Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.
Tang J, Shelton B, Makhatadze N, Zhang Y, Schaen M, Louie L
J Virol. 2001; 76(2):662-72.
PMID: 11752157
PMC: 136835.
DOI: 10.1128/jvi.76.2.662-672.2002.
